Cardiac Adenylyl Cyclase and Phosphodiesterase Expression Profiles Vary by Age, Disease, and Chronic Phosphodiesterase Inhibitor Treatment
- 14 July 2016
- journal article
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 23 (1) , 72-80
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Stress-dependent dilated cardiomyopathy in mice with cardiomyocyte-restricted inactivation of cyclic GMP-dependent protein kinase IEuropean Heart Journal, 2011
- A Kinase–Anchoring Proteins and Adenylyl Cyclase in Cardiovascular Physiology and PathologyJournal of Cardiovascular Pharmacology, 2011
- Impact of Oral Sildenafil on Exercise Performance in Children and Young Adults After the Fontan OperationCirculation, 2011
- Conserved expression and functions of PDE4 in rodent and human heartBasic Research in Cardiology, 2010
- Myocardial Remodeling Is Controlled by Myocyte-Targeted Gene Regulation of Phosphodiesterase Type 5JACC, 2010
- Adenylyl Cyclase 6 Deletion Reduces Left Ventricular Hypertrophy, Dilation, Dysfunction, and Fibrosis in Pressure-Overloaded Female MiceJACC, 2010
- Differential Association of Phosphodiesterase 4D Isoforms with β2-Adrenoceptor in Cardiac MyocytesJournal of Biological Chemistry, 2009
- Adenylyl cyclase type 5 protein expression during cardiac development and stressAmerican Journal of Physiology-Heart and Circulatory Physiology, 2009
- An Adenylyl Cyclase-mAKAPβ Signaling Complex Regulates cAMP Levels in Cardiac MyocytesJournal of Biological Chemistry, 2009
- Cyclic GMP signaling in cardiovascular pathophysiology and therapeuticsPharmacology & Therapeutics, 2009